Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
SEALSQ Corp highlights progress in its SEALQuantum strategy via Quobly, a French quantum computing company focused on industrially scalable silicon-based quantum processors. SEALSQ has made a significant investment in Quobly's €115 million Series A funding and entered a $5 million commercial agreement to integrate post-quantum security technologies…
Zeo Energy Corp. has entered into a collaboration agreement with Fulcrum Point Holdings, designating Zeo as Fulcrum's primary energy storage and commercial solar developer for power projects. The partnership aims to leverage Zeo's storage technology and Fulcrum's gas development expertise to improve project economics, reduce emissions, and accelera…
Roper Technologies, a Nasdaq 100 and Fortune 500 constituent, announced they will present at the Piper Sandler Growth Frontiers Conference on September 15, 2026. The presentation will be webcast for investors. Roper highlights its strategy of generating cash flow, shareholder value, and deploying capital through acquisitions in niche technology mar…
Bone Biologics Corporation announced the expansion of its first-in-human pilot clinical trial for its lead bone graft product, NB1, by adding six hospital sites in Australia. This expansion will double the number of participating centers, likely speeding patient enrollment and surgical scheduling with an anticipated completion by the end of 2026. T…
Vericel Corporation, a leader in advanced therapies for sports medicine and severe burn care, announced it will present at the 24th Annual Morgan Stanley Global Healthcare Conference. The presentation will highlight the company's innovative cell therapies and specialty biologics, including MACI, Epicel, and NexoBrid, marketed in the United States.
Optimi Health Corp., a commercial-stage pharmaceutical manufacturer specializing in regulated psychedelic drug products, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference where management will present and be available for meetings. The company produces GMP-grade MDMA and psilocybin products, supplying to cl…
Lifeward Ltd., a biomedical innovation company traded on Nasdaq under ticker LFWD, has released an updated investor presentation highlighting its strategy to scale its neurorehabilitation platform, leverage reimbursement infrastructure, and expand its distribution network. The company also emphasizes its diversified biomedical pipeline, including a…
Tempest Therapeutics, a clinical-stage biotech company developing advanced in vivo CAR-T therapies for cancer and autoimmune diseases, announced that CEO Matt Angel will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company's progress and pipeline, notably their lead candidate TPST-4003. Th…
Liberty Defense Holdings Ltd. announced the debut of the HEXWAVE I-Configuration at the GSX 2026 event in Atlanta. This new single-panel millimeter wave detection system enables full-body threat scanning in constrained entry points by having individuals rotate once in front of the sensor, enhancing security screening in areas where multi-panel setu…
NeoVolta Inc., a U.S.-based energy technology company specializing in scalable energy storage solutions, announced its financial results release for Q4 and fiscal year ended June 30, 2026. The earnings will be disclosed after market close on September 23, 2026, followed by a conference call to discuss operational progress, strategic priorities, and…
ZenaTech plans to leverage its recent acquisition of Florida-based Green Earth Powerwashing LLC to develop a franchise-based Drone as a Service (DaaS) power washing business. The company aims to integrate AI drone technology to improve safety, speed, and service consistency, initially targeting Florida's dense high-rise and commercial property mark…
Draganfly Inc. has been selected as a qualified supplier across all five capability streams of Canada's Defence Drone Initiative Marketplace, enabling the company to engage in contract opportunities with Canadian Armed Forces and Coast Guard. This selection aligns Draganfly with Canada's $180 billion defense procurement investment over the next dec…
StablecoinX Inc., the Nasdaq-listed company focused on the Ethena digital dollar ecosystem, announced the appointment of Christopher Jensen as CEO and board director. Jensen, with extensive institutional investment and digital asset experience from Franklin Templeton, succeeds Ted Chen who remains chairman. Jensen will lead day-to-day operations ac…
Quoin Pharmaceuticals Ltd. announced the FDA has granted Rare Pediatric Disease (RPD) Designation for its lead drug candidate QRX003 for treating Peeling Skin Syndrome (PSS), marking its second RPD designation following one for Netherton Syndrome. This designation could enable Quoin to receive a Priority Review Voucher (PRV) with estimated market v…
Surrozen, Inc. has submitted an Investigational New Drug (IND) application for SZN-8141, a bifunctional antibody designed to treat diabetic macular edema by combining Wnt pathway activation and VEGF inhibition. This dual mechanism aims to reduce vascular leakage and promote retinal vascular integrity. Preclinical studies showed superior efficacy of…
PDS Biotechnology Corporation announced a private equity financing of up to $22.55 million led by Nant Capital, with Dr. Patrick Soon-Shiong joining as a board member. The funding will support late-stage clinical development of PDS0301, an immunocytokine targeting solid tumors, especially difficult-to-treat metastatic colorectal cancer. The transac…
CRISPR Therapeutics, a leader in gene-editing based biopharmaceuticals, announced a scheduled presentation at the Morgan Stanley 24th Annual Global Healthcare Conference. The company recently marked a historic milestone with the approval of CASGEVY®, the world's first CRISPR-based therapy, and continues to advance a robust pipeline across multiple …
Greenland Mines has entered a new strategic phase as a rare earths and critical minerals company after Nasdaq approved its transaction application, ensuring full compliance with listing requirements. The company recently closed the $2.05 billion high-case NPV Sarfartoq rare earth project acquisition, highlighting its focus on neodymium and praseody…
Dynagas LNG Partners LP announced its financial results for Q2 and H1 2026, reporting increased net income and steady fleet utilization of above 95%. The partnership highlights improved charter rates, reduced debt costs, and a healthy revenue backlog of $0.73 billion with an average contract term of 4.4 years. However, geopolitical tensions and evo…
Orion Energy Systems announced a significant follow-up order to deploy its high-efficiency MPHL2 LED Lighting system for a leading global data center operator, just three months after an initial multimillion-dollar deployment. This continued engagement underscores Orion’s growing role in the hyperscale data center market, driven by its energy-effic…
Can-Fite BioPharma announced Q2 2026 financial results alongside key clinical progress. The pivotal Phase III study in liver cancer showed longer-than-expected overall survival while maintaining a blinded status, prompting consideration for an earlier interim analysis. Positive durable survival outcomes were also observed in a Phase IIa pancreatic …
Veru Inc. announced positive preclinical data showing oral sabizabulin's potent anticancer activity against KRAS-driven metastatic pancreatic cancer cell lines resistant to FDA-approved daraxonrasib. Based on these results and prior clinical safety and efficacy data, the company plans to initiate a Phase 2b clinical trial for sabizabulin in patient…
Worthington Enterprises Inc. (NYSE: WOR) announced its fiscal first quarter 2027 earnings call scheduled for September 23, 2026. The company will release its quarterly financial results after market close on September 22, followed by a live webcast conference call. Worthington Enterprises operates in building products and consumer products sectors …
GRI Bio, Inc. announced new comprehensive Phase 2a clinical data for its oral drug candidate GRI-0621 in idiopathic pulmonary fibrosis (IPF). The study highlights nine mechanistic pillars supporting GRI-0621's action, including immune modulation, anti-fibrotic effects, basement membrane repair, and alveolar epithelial regeneration. Results also sho…
Phillips Edison & Company, Inc., a leading owner and operator of grocery-anchored shopping centers, announced that its CFO John Caulfield will participate in the Retail REIT Panel at the Barclays 24th Annual Global Financial Services Conference on September 14, 2026. The event will be webcast and a replay will be available on the company's investor…
